VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Solid Biosciences Inc. (SLDB) Total Return Calculator with Dividends Reinvested

Solid Biosciences Inc.

Popular:

The total return for Solid Biosciences Inc. (SLDB) stock is +172.97% over the past 12 months. So far it's up 29.72% this year. The 5-year total return is -90.01%, meaning $10,000 invested in SLDB stock 5 years ago would be worth $999 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in SLDB 1 year ago, it would be worth $25,523 today — you'd have gained $15,523.

With Dividends Reinvested$25,523+155.23%

Price Only (No DRIP)$25,523+155.23%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in SLDB

1Y$27,297+$17,297 (+173.0%)173.0% CAGR

3Y$13,068+$3,068 (+30.7%)9.3% CAGR

5Y$999-$9,001 (-90.0%)-36.9% CAGR

10Y$208-$9,792 (-97.9%)-32.1% CAGR

15Y$208-$9,792 (-97.9%)-22.7% CAGR

20Y$208-$9,792 (-97.9%)-17.6% CAGR

30Y$208-$9,792 (-97.9%)-12.1% CAGR

Solid Biosciences Inc. did not pay dividends during this period. Total return = price return.

Loading SLDB total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+29.72%	—	+29.72%	—	$12,972
1Y	+172.97%	172.97%	+172.97%	—	$27,297
3Y	+30.68%	9.33%	+30.68%	—	$13,068
5Y	-90.01%	-36.92%	-90.01%	—	$999
10Y	-97.92%	-32.10%	-97.92%	—	$208
15Y	-97.92%	-22.75%	-97.92%	—	$208
20Y	-97.92%	-17.60%	-97.92%	—	$208
30Y	-97.92%	-12.11%	-97.92%	—	$208

Risk & Highlights

Best Year+71.11%2020

Worst Year-84.61%2019

Max Drawdown-44.41%2025-07-30 → 2025-11-05 · Recovered 2026-03-09

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+13.94%	+13.94%	—	+0.41%	+13.5pp
2025	+44.62%	+44.62%	—	+16.64%	+28.0pp
2024	-36.00%	-36.00%	—	+24.00%	-60.0pp
2023	+9.25%	+9.25%	—	+24.81%	-15.6pp
2022	-79.85%	-79.85%	—	-19.95%	-59.9pp

SLDB outperformed the S&P 500 by 142.60pp over the past year (+172.97% vs +30.37%).

Loading summary...

SLDB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
SLDBSolid Biosciences Inc.	$551M	-8.7%	+29.7%	+173.0%	—	+30.7%	-90.0%	-97.9%
SRPTSarepta Therapeutics, Inc.	$2.2B	-9.9%	-2.4%	-43.4%	—	-83.6%	-72.1%	+18.0%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
SGMOSangamo Therapeutics, Inc.	$22M	-60.5%	-77.0%	-84.4%	—	-92.0%	-99.0%	-98.4%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
EDITEditas Medicine, Inc.	$297M	+10.6%	+47.8%	+127.8%	—	-68.5%	-91.1%	-90.0%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
ARWRArrowhead Pharmaceuticals, Inc.	$10.9B	+27.4%	+15.0%	+496.9%	—	+92.7%	+17.4%	+1253.3%

Compare:SLDB vs SRPT SLDB vs CRSP SLDB vs SGMO SLDB vs SRPT vs CRSP

About SLDB Dividend Returns

Solid Biosciences Inc. (SLDB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of SLDB over the past year?

Solid Biosciences Inc. (SLDB) delivered a return of 172.97% over the past year. Since SLDB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in SLDB be worth today?

A $10,000 investment in Solid Biosciences Inc. one year ago would be worth $27,297 today, representing a gain of $17,297.

Q3Does SLDB pay dividends?

Solid Biosciences Inc. (SLDB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SLDB, the total return equals the price-only return.

Q4Did SLDB beat the S&P 500?

Yes, Solid Biosciences Inc. (SLDB) outperformed the S&P 500 by 142.60 percentage points over the past year. SLDB delivered a total return of 172.97%, compared to the S&P 500's 30.37%. This 142.60pp alpha means investors in SLDB earned more than a passive S&P 500 index fund.

Q5What is SLDB's worst drawdown?

Solid Biosciences Inc. (SLDB) experienced a maximum drawdown of -44.41% over the past year, declining from its peak on 2025-07-30 to its trough on 2025-11-05. The stock recovered to its prior peak by 2026-03-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is SLDB's long-term total return over 10, 20, or 30 years?

Here are Solid Biosciences Inc. (SLDB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -97.9% (-32.1% CAGR) — $10,000 would have grown to $208. Over 20 years: -97.9% total return (-17.6% CAGR) — $10,000 → $208. Over 30 years: -97.9% total return (-12.1% CAGR) — $10,000 → $208. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was SLDB's best and worst year?

Solid Biosciences Inc.'s best calendar year was 2020 with a total return of 71.1%. Its worst year was 2019 with a total return of -84.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 155.7 percentage points.